European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

Registration to the ESTIV 2024 Congress in Prague, June 3-6 is open!

  • News

We are pleased to announce that the registration for the 22nd international congress of the European Society of Toxicology In Vitro (ESTIV2024) is open now! The congress will take place 3 – 6 June 2024 in Cubex Centre in Prague, Czech Republic.

ESTIV 2024 Congress bursary for the winner of the ASPIS Open Symposium Best Poster Award

  • News

ESTIV 2024 Congress bursary for the winner of the ASPIS Open Symposium Best Poster Award

IVTIP donation to support the ESTIV training courses

  • News

IVTIP has chosen to transfer its remaining funds to ESTIV, recognizing our shared commitment to excellence in toxicology education.

Gold Sponsor

Memorandum of Understanding